Cytosorbents (CTSO) Short-term Investments (2014 - 2024)
Cytosorbents posted quarterly Short-term Investments of $5.0 million for Q4 2024, up 1908.03% on a QoQ basis from $249000.0 in Q2 2016.
Cytosorbents (CTSO) has 4 years of Short-term Investments data on file, last reported at $5.0 million in Q4 2024.
- For the quarter ending Q4 2024, Short-term Investments changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2024 stood at $5.0 million (changed N/A YoY), and the FY2024 full-year result was $5.0 million, changed N/A from the prior year.
- Short-term Investments for Q4 2024 stood at $5.0 million, up from $249000.0 in the prior quarter.
- Across five years, Short-term Investments topped out at $5.0 million in Q4 2024 and bottomed at $5.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.00 Mn |
| Jun 30, 2016 | 249,000.00 |
| Mar 31, 2016 | 2.49 Mn |
| Dec 31, 2015 | 2.19 Mn |
| Dec 31, 2014 | 1.94 Mn |
| Sep 30, 2014 | 7.35 Mn |
| Jun 30, 2014 | 4.75 Mn |
| Mar 31, 2014 | 4.75 Mn |